Carolyn Cross Purchases 149,225 Shares of Ondine Biomedical Inc. (LON:OBI) Stock

Ondine Biomedical Inc. (LON:OBI) insider Carolyn Cross purchased 149,225 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The shares were purchased at an average price of C$13.00 per share, for a total transaction of C$1,939,925.00.

Carolyn Cross also recently made the following trade(s):

• On Thursday, January 30th, Carolyn Cross purchased 200,775 shares of Ondine Biomedical stock. The shares were acquired at an average cost of C$12.00 per share, with a total value of C$2,409,300.00.

Ondine Biomedical Stock Performance

Shares of OBI opened at C$12.50 on Friday. Ondine Biomedical Inc. has a 52 week low of C$4.50 and a 52 week high of C$13.30. The company has a quick ratio of 8.26, a current ratio of 0.80 and a debt-to-equity ratio of 1,847.37. The stock has a market cap of C$3.47 billion, a P/E ratio of -416.67 and a beta of 0.10. The business’s 50 day moving average price is C$9.52 and its 200-day moving average price is C$8.10.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.